Jackson Thornton Wealth Management’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$395K Buy
+1,829
New +$350K 0.03% 200
2026
Q1
– Sell
-1,297
Closed -$237K – 296
2025
Q4
$237K Buy
+1,297
New +$212K 0.02% 261

Other funds holding BIIB

Jackson Thornton Wealth Management's BIIB Position: Q2 2026 in Review

Jackson Thornton Wealth Management opened a new position in Biogen (BIIB) in Q2 2026: 1,829 shares worth $395K. The stake represents 0.03% of the portfolio and ranks #200 among its holdings. This is a return to the name: Jackson Thornton Wealth Management previously reported a position in BIIB as recently as Q4 2025.

Jackson Thornton Wealth Management first reported a position in BIIB in Q4 2025 and has held it in 2 quarters since. 1,046 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

  • Jackson Thornton Wealth Management held 1,829 shares of Biogen worth $395K as of Q2 2026.
  • Biogen was a new Jackson Thornton Wealth Management position in Q2 2026.
  • Biogen made up 0.03% of Jackson Thornton Wealth Management's portfolio in Q2 2026, its #200 holding.
  • Jackson Thornton Wealth Management first reported a position in Biogen in Q4 2025 and has held it in 2 quarters since.
  • 1,046 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Jackson Thornton Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.